FDA-Cleared Access Program Bodes Well For HeartMate Trial, Thoratec Says
This article was originally published in The Gray Sheet
Executive Summary
FDA's decision allowing Thoratec to make the HeartMate VE battery-powered left ventricular assist system available to patients outside its IDE trial indicates preliminary survival data are "very encouraging," the company says.